 |
The Journal of Neuroscience, April 6, 2005, 25(14):3621-3627; doi:10.1523/JNEUROSCI.4213-04.2005
Previous Article | Next Article 
Neurobiology of Disease
Apolipoprotein E Genotype Regulates Amyloid- Cytotoxicity
Micha M. M. Wilhelmus,1,2
Irene Otte-Höller,2
Judianne Davis,3
William E. Van Nostrand,3
Robert M. W. de Waal,2 and
Marcel M. Verbeek1,2
Departments of 1Neurology and 2Pathology, Radboud University Nijmegen Medical Center, 6500 HB Nijmegen, The Netherlands, and 3Department of Medicine, Health Sciences Center, Stony Brook University, Stony Brook, New York 11794-8153
The 4 allele of apolipoprotein E (ApoE) is a risk factor for Alzheimer's disease (AD), whereas the 2 allele may be relatively protective. Both alleles are risk factors for cerebral amyloid angiopathy (CAA)-related hemorrhages. CAA is associated with degeneration of smooth muscle cells and pericytes. Previously, we described that synthetic amyloid- 1-40 peptide (A 1-40) with the 22Glu Gln "Dutch" mutation caused pericyte death in vitro by a mechanism that involves A fibril-like assembly at the cell surface. It is known that ApoE binds to A and may modify its biological activities. In the present study, we evaluated the effect of ApoE on A -mediated toxicity of cerebrovascular cells. We observed that cultured cells with an 4/ 4 genotype were more vulnerable to A than cultures with an 3/ 3 or 3/ 4 genotype. The one cell culture with the 2/ 3 genotype was relatively resistant to A compared with other cultures. Furthermore, we observed a dose-dependent protective effect of native ApoE against A -mediated toxicity of cerebrovascular cells and, in addition, ApoE 2/ 3 cells secreted more ApoE protein compared with cells with other ApoE genotypes, in particular, compared with 4/ 4 cells. Thus, the disparity between ApoE genotype and A -mediated toxicity might be related to differences in the cellular capacity to secrete ApoE. The present data suggest that one mechanism by which ApoE may alter the risk for AD is a genotype-dependent regulation of A cytotoxicity, possibly via variations in its secretion levels, whereby extracellular ApoE may bind to A and thereby modify A -mediated cell death.
Key words: apolipoprotein E; Alzheimer's disease; amyloid- protein; cerebrovascular cells; CAA; cytotoxicity
Received Oct 11, 2004;
revised February 21, 2005;
accepted February 23, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
F. Xu, M. P. Vitek, C. A. Colton, M. L. Previti, N. Gharkholonarehe, J. Davis, and W. E. Van Nostrand
Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice
J. Neurosci.,
May 14, 2008;
28(20):
5312 - 5320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M.M. Wilhelmus, I. Otte-Holler, J. J.J. van Triel, R. Veerhuis, M. L.C. Maat-Schieman, G. Bu, R. M.W. de Waal, and M. M. Verbeek
Lipoprotein Receptor-Related Protein-1 Mediates Amyloid- -Mediated Cell Death of Cerebrovascular Cells
Am. J. Pathol.,
December 1, 2007;
171(6):
1989 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|